← Browse by Condition
Medical Condition

osteoporosis

Total Trials
15
Recruiting Now
15
Trial Phases
Phase 2, Phase 4

ClinicalMetric tracks all active clinical trials for osteoporosis sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — osteoporosis Clinical Trials

How many clinical trials are currently recruiting for osteoporosis?
ClinicalMetric currently tracks 15 actively recruiting clinical trials for osteoporosis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 15. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for osteoporosis?
osteoporosis research spans Phase 2 (2 trials), Phase 4 (3 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a osteoporosis clinical trial?
Eligibility criteria for osteoporosis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
2
Phase 4
3
Top Sponsors
VA Office of Research and Development 1 trial
Australian and New Zealand Intensive Care Research Centre 1 trial
Kanuni Sultan Suleyman Training and Research Hospital 1 trial
Peking University People's Hospital 1 trial
Aarhus University Hospital 1 trial

Recruiting Clinical Trials

NCT05266976
Recruiting
Mode of Exercise and Bone Biomarkers in Older Veterans
Enrollment
120 pts
Location
United States
Sponsor
VA Office of Research and Deve...
View Trial →
NCT04608630 Phase 2
Recruiting
Bone Loss Prevention With Zoledronic Acid or Denosumab in Critically Ill Adults
Enrollment
450 pts
Location
Australia, New Zeala...
Sponsor
Australian and New Zealand Int...
View Trial →
NCT07677033
Recruiting
Functional Muscle-Bone Incongruity Index (FKUI): A Prospective Observational Study
Enrollment
200 pts
Location
Turkey (Türkiye)
Sponsor
Kanuni Sultan Suleyman Trainin...
View Trial →
NCT07474571
Recruiting
Evaluation of Musculoskeletal Aging and Related Disorders Via Advanced Clinical Imaging
Enrollment
2,000 pts
Location
China
Sponsor
Peking University People's Hos...
View Trial →
NCT07271771 Phase 4
Recruiting
The Effect of Denosumab on Muscle and Strength and Insulin Sensitivity
Enrollment
40 pts
Location
Denmark
Sponsor
Aarhus University Hospital
View Trial →
NCT06915935
Recruiting
Epidemiological Study of Osteoporosis in the Elderly Population of Shandong Province
Enrollment
2,000 pts
Location
China
Sponsor
The Second Hospital of Shandon...
View Trial →
NCT05246813
Recruiting
Metabolic Profiling of Hematopoietic Stem Cells in Clonal Hematopoiesis (CHIP)
Enrollment
24 pts
Location
Belgium
Sponsor
Imelda Hospital, Bonheiden
View Trial →
NCT06938152 Phase 4
Recruiting
Effects of Cycle Therapy vs Sequential Therapy With Romosozumab and Denosumab in Postmenopausal Osteoporosis Patients
Enrollment
70 pts
Location
Taiwan
Sponsor
National Taiwan University Hos...
View Trial →
NCT06838702
Recruiting
Structured Data Collection of Patients Undergoing Liver Transplantation and Evaluated for Bone Mineral Metabolism
Enrollment
150 pts
Location
Italy
Sponsor
IRCCS Azienda Ospedaliero-Univ...
View Trial →
NCT04787679
Recruiting
Image-guided Computational and Experimental Analyses of Fractured Patient's Bone (GAP)
Enrollment
52 pts
Location
Italy
Sponsor
Laura Maria Vergani
View Trial →
NCT07597850 Phase 2
Recruiting
TCM Formula vs. HMB in Pre-Frail Elders: Muscle Strength and Bone Status
Enrollment
90 pts
Location
Taiwan
Sponsor
Tri-Service General Hospital (...
View Trial →
NCT07288684
Recruiting
Chiropractor Delivered Virtual Intervention After Vertebral frActure
Enrollment
15 pts
Location
Canada
Sponsor
University of Waterloo
View Trial →
NCT07301892
Recruiting
Generative AI Impact on Rheumatoid Arthritis Complications Diagnosis
Enrollment
100 pts
Location
China
Sponsor
Guang'anmen Hospital of China ...
View Trial →
NCT03699228
Recruiting
China Health Big Data
Enrollment
30,000 pts
Location
China
Sponsor
Beijing Jishuitan Hospital
View Trial →
NCT07154719 Phase 4
Recruiting
GLP-1R Actions on Muscle and the Skeleton
Enrollment
50 pts
Location
United States
Sponsor
Pennington Biomedical Research...
View Trial →

Related Conditions

aging (3) sarcopenia (2) obesity (2) musculoskeletal diseases (1) critical illness (1) musculoskeletal health (1) osteopenia (1) osteoarthitis (1) osteoporosis senile (1) osteoarthritis hip (1) hip fractures (1) clonal hematopoiesis of indeterminate potential (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology